GOSSAMER BIO, INC. Cash Flow Breakdown
Cash flow breakdown shows where GOSSAMER BIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.
- Fiscal year ended 2025-12-31: from running the business, $171.27M went out.
- Fiscal year ended 2025-12-31: from investing, $156.36M came in.
- Fiscal year ended 2025-12-31: from financing, $6.42M came in.
- Fiscal year ended 2025-12-31: change in cash, $8.34M went out.
A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.
Each year (12 month)
| Fiscal year end | Running the business | From investing | Debt paid back | New debt | New shares sold | Not split out | Change in cash |
|---|
| 2025-12-31 | -$171.27M | $156.36M | $0.00 | | $1.93M | $4.50M* | -$8.34M |
|---|
| 2024-12-31 | -$3.47M | $29.02M | -$12.58M | | $0.00 | $1.09M* | $13.96M |
|---|
| 2023-12-31 | -$159.16M | -$110.97M | -$11.61M | | $0.00 | $201.77M* | -$79.86M |
|---|
| 2022-12-31 | -$187.03M | -$1.03M | -$5.81M | | $1.74M | $121.16M* | -$71.49M |
|---|
| 2021-12-31 | -$188.89M | -$117.43M | $0.00 | | $2.01M | $1.31M* | -$303.15M |
|---|
| 2020-12-31 | -$176.36M | $215.34M | $0.00 | | $117.11M | $195.43M* | $351.53M |
|---|
| 2019-12-31 | -$144.83M | -$147.14M | | $28.22M | $291.31M | $2.04M* | $29.67M |
|---|
| 2018-12-31 | -$51.04M | -$144.71M | | | $0.00 | $300.86M* | $105.10M |
|---|
| 2017-12-31 | -$5.75M | | | | | $6.00M* | $255.00K |
|---|
Each quarter (3 month)
| Quarter end | Running the business | From investing | Debt paid back | New debt | New shares sold | Not split out | Change in cash |
|---|
| 2026-06-30 | -$39.42M* | $42.70M* | | | $0.00* | -$3.14M* | |
|---|
| 2026-03-31 | -$38.72M | $41.61M | | | $220.00K | | $3.30M |
|---|
| 2025-12-31 | -$48.31M* | $73.16M* | $0.00* | | $1.24M* | $2.72M* | |
|---|
| 2025-09-30 | -$36.17M* | $17.01M* | $0.00* | | $465.00K* | $1.41M* | |
|---|
| 2025-06-30 | -$47.06M* | $44.13M* | $0.00* | | $94.00K* | | |
|---|
| 2025-03-31 | -$39.72M | $22.06M | $0.00 | | $132.00K | | -$17.05M |
|---|
| 2024-12-31 | -$35.48M* | $53.22M* | $0.00* | | $0.00* | | |
|---|
| 2024-09-30 | -$32.03M* | -$26.75M* | $0.00* | | $0.00* | | |
|---|
| 2024-06-30 | $116.35M* | -$59.11M* | -$9.68M* | | $0.00* | | |
|---|
| 2024-03-31 | -$52.30M | $61.67M | -$2.90M | | $0.00 | | $6.75M |
|---|
| 2023-12-31 | -$33.42M* | -$14.37M* | -$2.90M* | | $0.00* | | |
|---|
| 2023-09-30 | -$34.49M* | -$118.26M* | -$2.90M* | | $77.00K* | $201.32M* | |
|---|
| 2023-06-30 | -$38.25M* | $12.94M* | -$2.90M* | | $0.00* | | |
|---|
| 2023-03-31 | -$52.99M | $8.72M | -$2.90M | | $367.00K | | -$46.73M |
|---|
| 2022-12-31 | -$47.73M* | $8.46M* | -$2.90M* | | $13.00K* | | |
|---|
| 2022-09-30 | -$37.00M* | -$22.60M* | -$2.90M* | | $1.58M* | $120.55M* | |
|---|
| 2022-06-30 | -$48.82M* | $4.68M* | $0.00* | | $21.00K* | | |
|---|
| 2022-03-31 | -$53.48M | $8.42M | $0.00 | | $126.00K | $595.00K* | -$44.50M |
|---|
| 2021-12-31 | -$40.51M* | $10.44M* | $0.00* | | $371.00K* | | |
|---|
| 2021-09-30 | -$42.03M* | -$89.76M* | | | $1.36M* | $556.00K* | |
|---|
| 2021-06-30 | -$47.45M* | -$50.08M* | | | $271.00K* | | |
|---|
| 2021-03-31 | -$58.90M | $11.97M | | | $15.00K | $759.00K* | -$46.40M |
|---|
| 2020-12-31 | -$36.74M* | $61.10M* | | | $0.00* | | |
|---|
| 2020-09-30 | -$44.93M* | $19.96M* | | | $16.00K* | $875.00K* | |
|---|
| 2020-06-30 | -$42.40M* | $106.25M* | | | $139.00K* | $310.69M* | |
|---|
| 2020-03-31 | -$52.30M | $28.04M | | | $15.00K | $556.00K* | -$23.69M |
|---|
| 2019-12-31 | -$44.14M* | $46.93M* | | $0.00* | $0.00* | $1.52M* | |
|---|
| 2019-09-30 | -$36.11M* | $17.95M* | | $0.00* | $0.00* | | |
|---|
| 2019-06-30 | -$36.81M* | -$13.88M* | | | $38.00K* | $28.31M* | |
|---|
| 2019-03-31 | -$27.77M | -$198.14M | | | $291.27M | | $65.43M |
|---|
| 2018-12-31 | -$25.02M* | -$8.68M* | | | | -$2.14M* | |
|---|
| 2018-09-30 | -$15.52M* | -$105.12M* | | | | $229.55M* | |
|---|
| 2018-06-30 | -$6.80M* | -$41.58M* | | | | $1.55M* | |
|---|
| 2018-03-31 | -$3.71M | $10.66M | | | | $71.90M* | $78.86M |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|